Sun Pharmaceutical is currently trading at RS 1765.00, up by 21.90 points or 1.26% from its previous closing of RS 1743.10 on the BSE.

The stock opened at RS 1749.95 and has touched a high of RS 1789.50 and a low of RS 1743.95 so far. A total of 24,815 shares have been traded on the counter.

The BSE Group 'A' stock, with a face value of RS 1, has recorded a 52-week high of RS 1960.20 on 30-Sep-2024 and a 52-week low of RS 1376.75 on 04-Jun-2024.

In the past week, the stock has fluctuated between a high of RS 1822.15 and a low of RS 1693.65. The company's current market capitalization stands at RS 4,22,834.80 crore.

The promoter holding in the company is at 54.48%, while Institutions and Non-Institutions hold 36.59% and 8.93%, respectively.

Sun Pharmaceutical Industries has reported a 63.74% rise in its net profit to RS 1181.05 crore for the third quarter ended December 31, 2024, compared to RS 721.31 crore in the same quarter of the previous year. The company's total income increased by 21.54% to RS 6260.20 crore for Q3FY25, compared to RS 5150.55 crore in the corresponding quarter of the previous year.

On a consolidated basis, the company reported a 13.61% rise in net profit to RS 2917.54 crore for the quarter ended December 31, 2024, compared to RS 2568.03 crore in the same quarter last year. The total income rose by 11.96% to RS 14,141.08 crore for Q3FY25, compared to RS 12,630.90 crore in the corresponding quarter last year.